An Assessment of Opioid Overdoses in San Francisco from 2010 through 2012

对 2010 年至 2012 年旧金山阿片类药物过量的评估

基本信息

  • 批准号:
    8764664
  • 负责人:
  • 金额:
    $ 5.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-07-01 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Drug poisoning is now the leading cause of accidental death among adults in the U.S. and opioid analgesic overdose deaths dramatically increased by over 400% and 265% among women and men, respectively, from 1999-2010. The economic cost of opioid-related poisoning was estimated at $20.4 billion in the United States for 2009. Addressing opioid overdose is consistent with the White House goal of reducing drug-induced morbidity and mortality by 15%. San Francisco, historically a leading city for opioid use and related morbidity, witnessed a dramatic decline in heroin-related mortality after improving access to agonist maintenance services and implementing city-wide distribution of naloxone (the short-acting opioid antagonist used to reverse opioid overdose). However, a surge in opioid analgesic mortality negated much of this mortality benefit. We still understand little about "who" dies from opioid analgesics since there is no local system for monitoring opioid overdose indicators. Moreover, it is unclear how agonist maintenance services and naloxone distribution correlate with geographic concentration of opioid overdose deaths. To effectively respond to opioid overdose, it is critical to develop methods to identify and monitor overdose trends and evaluate the effectiveness of interventions. We propose a secondary analysis of opioid overdose decedent data collected from the California State Electronic Death Reporting System (EDRS) matched with data from the public substance use treatment record database and chart review of all patients cared for in the safety net healthcare system affiliated with the San Francisco Department of Public Health. We will evaluate annuals trends in opioid overdose deaths for San Francisco, overall and by neighborhood using Poisson regression models form 2010-2012 (aim 1). We will also describe the demographic and clinical characteristics of opioid overdose decedents in San Francisco County using toxicology and medical and substance use treatment records (aim 2). W explores the spatial overlap between opioid overdose decedents, lay naloxone distribution and lay naloxone use (aim 3). In exploratory aims, we will calculate the rate of opioid overdose mortality using US census, National HIV Behavioral Surveillance, and prescription drug monitoring program data for denominators, and conduct ecological analyses to look at the relationship between opioid overdose deaths and neighborhood-level factors. Findings from this study will inform the development of a local surveillance system to track opioid-related outcomes, strengthen the capacity to monitor opioid overdose mortality and enhance interventions to reduce opioid overdose mortality.
描述(由申请人提供):药物中毒现在是美国成年人意外死亡的主要原因,从1999年到2010年,女性和男性阿片类镇痛药过量死亡人数分别急剧增加了400%和265%以上。2009年,美国类阿片相关中毒的经济成本估计为204亿美元。解决阿片类药物过量与白宫将药物引起的发病率和死亡率降低15%的目标一致。旧金山弗朗西斯科历来是阿片类药物使用和相关发病率的主要城市,在改善了激动剂维持服务的可及性并在全市范围内分发纳洛酮(用于逆转阿片类药物过量的短效阿片类拮抗剂)后,海洛因相关死亡率大幅下降。然而,阿片类镇痛药死亡率的激增抵消了这种死亡率的大部分好处。我们仍然对“谁”死于阿片类镇痛剂知之甚少,因为没有监测阿片类药物过量指标的地方系统。此外,目前还不清楚激动剂维持服务和纳洛酮分布与阿片类药物过量死亡的地理集中度之间的关系。为了有效应对阿片类药物过量,至关重要的是要制定方法来确定和监测过量趋势,并评估干预措施的有效性。我们建议对从加州州电子死亡报告系统(EDRS)收集的阿片类药物过量死者数据进行二次分析,这些数据与来自公共物质使用治疗记录数据库的数据相匹配,并对弗朗西斯科公共卫生部下属的安全网医疗保健系统中的所有患者进行图表审查。我们将使用泊松回归模型评估2010-2012年旧金山弗朗西斯科阿片类药物过量死亡的年度趋势(目标1)。我们还将使用毒理学、医疗和物质使用治疗记录描述旧金山弗朗西斯科县阿片类药物过量死亡者的人口统计学和临床特征(目的2)。W探索阿片类药物过量死亡者、非专业纳洛酮分布和非专业纳洛酮使用之间的空间重叠(目的3)。在探索性目标中,我们将使用美国人口普查,国家艾滋病毒行为监测和处方药监测计划数据计算阿片类药物过量死亡率,并进行生态分析,以了解阿片类药物过量死亡与社区因素之间的关系。这项研究的结果将为当地监测系统的发展提供信息,以跟踪阿片类药物相关的结果,加强监测阿片类药物过量死亡率的能力,并加强干预措施以减少阿片类药物过量死亡率。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PHILLIP O COFFIN其他文献

PHILLIP O COFFIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PHILLIP O COFFIN', 18)}}的其他基金

Midcareer K24 Award for Mentoring and Patient-Oriented Research
职业生涯中期 K24 指导和以患者为导向的研究奖
  • 批准号:
    10618740
  • 财政年份:
    2023
  • 资助金额:
    $ 5.49万
  • 项目类别:
Leveraging Psychological Autopsies to Accelerate Research into Stimulant Overdose Mortality
利用心理尸检加速兴奋剂过量死亡率的研究
  • 批准号:
    10387934
  • 财政年份:
    2021
  • 资助金额:
    $ 5.49万
  • 项目类别:
Leveraging Psychological Autopsies to Accelerate Research into Stimulant Overdose Mortality
利用心理尸检加速兴奋剂过量死亡率的研究
  • 批准号:
    10664991
  • 财政年份:
    2021
  • 资助金额:
    $ 5.49万
  • 项目类别:
PRIME: PrEP Intervention for people who Inject MEthamphetamine
PRIME:针对注射甲基苯丙胺患者的 PrEP 干预
  • 批准号:
    10223260
  • 财政年份:
    2020
  • 资助金额:
    $ 5.49万
  • 项目类别:
PRIME: PrEP Intervention for people who Inject MEthamphetamine
PRIME:针对注射甲基苯丙胺患者的 PrEP 干预
  • 批准号:
    10655538
  • 财政年份:
    2020
  • 资助金额:
    $ 5.49万
  • 项目类别:
PRIME: PrEP Intervention for people who Inject MEthamphetamine
PRIME:针对注射甲基苯丙胺患者的 PrEP 干预
  • 批准号:
    10424546
  • 财政年份:
    2020
  • 资助金额:
    $ 5.49万
  • 项目类别:
Mirtazapine for methamphetamine use disorder: drug-drug interaction study
米氮平治疗甲基苯丙胺使用障碍:药物相互作用研究
  • 批准号:
    9983371
  • 财政年份:
    2020
  • 资助金额:
    $ 5.49万
  • 项目类别:
PRIME: PrEP Intervention for people who Inject MEthamphetamine
PRIME:针对注射甲基苯丙胺患者的 PrEP 干预
  • 批准号:
    10054139
  • 财政年份:
    2020
  • 资助金额:
    $ 5.49万
  • 项目类别:
Repeated-dose behavioral intervention to reduce opioid overdose: a two-site randomized-controlled efficacy trial
重复剂量行为干预减少阿片类药物过量:一项两中心随机对照疗效试验
  • 批准号:
    9896799
  • 财政年份:
    2018
  • 资助金额:
    $ 5.49万
  • 项目类别:
Repeated-dose behavioral intervention to reduce opioid overdose: a two-site randomized-controlled efficacy trial
重复剂量行为干预减少阿片类药物过量:一项两中心随机对照疗效试验
  • 批准号:
    10374101
  • 财政年份:
    2018
  • 资助金额:
    $ 5.49万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.49万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 5.49万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 5.49万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 5.49万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 5.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 5.49万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 5.49万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 5.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 5.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 5.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了